News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Vivo Opportunity, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Exercised (in-or-at-the-money) 5,215,000 options to buy
@ $2.5, valued at
$13M
|
|
| 09/28/2023 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Exercised (in-or-at-the-money) 3,203,093 options to buy
@ $1.75, valued at
$5.6M
|
|
| 08/10/2023 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Bought 3,157,894 shares
@ $1.9, valued at
$6M
Bought 3,157,894 warrants
@ $2.47, valued at
$7.8M
|
|
| 09/08/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 600,000 shares
@ $3.6, valued at
$2.2M
|
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 800,000 shares
@ $27, valued at
$21.6M
|
|
| 01/28/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Exercised (in-or-at-the-money) 75,749 options to buy
@ $13.2, valued at
$999.9k
Exercised (in-or-at-the-money) 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Exercised (in-or-at-the-money) 324,740 options to buy
@ $13.2, valued at
$4.3M
|
|
| 02/09/2021 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Converted 944,056 shares
@ $0
Converted 472,296 shares
@ $0
Sold 62 shares
@ $20, valued at
$1.2k
Converted 1,092,080 shares
@ $0
Converted 317,922 shares
@ $0
Converted 345,568 shares
@ $0
Sold 144 shares
@ $20, valued at
$2.9k
Bought 175,733 shares
@ $20, valued at
$3.5M
Converted 150,802 shares
@ $0
Converted 43,901 shares
@ $0
Converted 47,718 shares
@ $0 |
|
| 02/09/2021 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Converted 1,933,185 shares
@ $0
Converted 266,948 shares
@ $0
Bought 103,372 shares
@ $17, valued at
$1.8M
Bought 14,275 shares
@ $17, valued at
$242.7k
Bought 357,353 shares
@ $17, valued at
$6.1M
Converted 713,203 preferred shares
@ $0
Converted 98,484 preferred shares
@ $0
Converted 364,138 preferred shares
@ $0
Converted 50,282 preferred shares
@ $0 |
|
| 07/21/2020 |
4
| Vivo Capital IX, LLC (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Bought 789,474 shares
@ $19, valued at
$15M
Converted 3,245,048 shares
@ $0
Bought 185,526 shares
@ $19, valued at
$3.5M
Converted 3,158,851 convertible preferred
@ $0 |
|
| 03/11/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 347 shares
@ $19.5, valued at
$6.8k
Sold 48 shares
@ $19.5, valued at
$936
Sold 133 shares
@ $19.5, valued at
$2.6k
|
|
| 02/11/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 1,134 shares
@ $22, valued at
$24.9k
Sold 157 shares
@ $22, valued at
$3.5k
Sold 4,614 shares
@ $22, valued at
$101.5k
Sold 1,451 shares
@ $21.4, valued at
$31.1k
Sold 200 shares
@ $21.4, valued at
$4.3k
Sold 5,904 shares
@ $21.4, valued at
$126.3k
|
|
| 02/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 2,673 shares
@ $22.2, valued at
$59.3k
Sold 369 shares
@ $22.2, valued at
$8.2k
Sold 10,878 shares
@ $22.2, valued at
$241.5k
Sold 1,459 shares
@ $22.1, valued at
$32.2k
Sold 201 shares
@ $22.1, valued at
$4.4k
Sold 5,940 shares
@ $22.1, valued at
$131.3k
Sold 1,037 shares
@ $21.7, valued at
$22.5k
Sold 143 shares
@ $21.7, valued at
$3.1k
Sold 4,220 shares
@ $21.7, valued at
$91.6k
|
|
| 01/31/2020 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Converted 75,759 shares
@ $0
Converted 1,455,576 shares
@ $0
Converted 324,783 shares
@ $0
Converted 1,000 options to buy
@ $0
Converted 19,213 options to buy
@ $0
Converted 4,287 options to buy
@ $0 |
|
| 03/25/2019 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 292,609 shares
@ $22.25, valued at
$6.5M
Sold 40,407 shares
@ $22.25, valued at
$899.1k
Sold 83,984 shares
@ $22.25, valued at
$1.9M
|
|
| 07/20/2018 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Converted 2,560,613 shares
@ $0
Converted 353,590 shares
@ $0
Converted 413,040 shares
@ $0
Converted 57,035 shares
@ $0
Bought 51,686 shares
@ $17, valued at
$878.7k
Bought 7,137 shares
@ $17, valued at
$121.3k
Bought 141,177 shares
@ $17, valued at
$2.4M
Bought 153,180 shares
@ $20.73, valued at
$3.2M
Converted 8,424,416 preferred shares
@ $0
Converted 1,163,311 preferred shares
@ $0
Converted 1,358,903 preferred shares
@ $0 |
|
|
|